Together we will beat cancer

Donate

Pursuing precision medicine in a flagship lung cancer trial

The National Lung Matrix Trial – a £25 million collaboration with pharmaceutical companies and the NHS – has been exploring how patients with non small cell lung cancer respond to more tailored, targeted treatments.

Read More

Cancer blood test uses ‘noise cancellation’ to improve sensitivity

Cancer Research UK scientists have developed a new way to analyse blood for evidence of cancer that could be up to ten times more sensitive than previous methods.

Read More

Blood test can quickly match advanced breast cancer patients to targeted treatments

New trial results show that a blood test can identify rare types of advanced breast cancer and help patients to access the right treatment more quickly.

Read More

Revolutionising radiotherapy: making a cornerstone cancer treatment more personal and powerful

We’re investing £56 million into radiotherapy research that will be carried out by a network of specialist institutes across the UK.

Read More

The breast cancer ‘avatar’ mice that could help personalise treatment 

The Personalised Breast Cancer Programme in Cambridge is pioneering ways to tackle hard-to-treat breast cancer.

Read More

Highly sensitive blood test could improve breast cancer treatment

A new blood test is one of the first to successfully monitor early-stage breast cancer, and could be up to 100 times more sensitive than existing tests.

Read More

NHS to ‘fast track’ new personalised cancer medicines – but it’s not ready quite yet

NHS England announced plans to fast track “revolutionary” new cancer drugs. But there’s still some way to go before these drugs might reach patients.

Read More

Rewriting the breast cancer rulebook 

Our scientists have found that breast cancer is not 1 but 10 different diseases, each with a different risk of coming back or spreading.

Read More

Molecular patterns could better predict breast cancer recurrence

New research suggests the genetic and molecular make-up of individual breast tumours holds clues to how a woman’s disease could progress.

Read More

‘Cutting edge’ CAR T cell immunotherapy approved in England. But is the NHS ready?

With two complex CAR T immunotherapies now approved on the NHS in England, we look at how the health service has had to react to these exciting new treatments.

Read More